Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Piribedil

Copy Product Info
😃Good
Catalog No. T3278Cas No. 3605-01-4
Alias Trivastan, Trivastal, EU-4200, ET-495

Piribedil (Trivastan) is a dopamine D2 agonist, used in the treatment of Parkinson's disease.

Piribedil

Piribedil

Copy Product Info
😃Good
Purity: 99.82%
Catalog No. T3278Alias Trivastan, Trivastal, EU-4200, ET-495Cas No. 3605-01-4
Piribedil (Trivastan) is a dopamine D2 agonist, used in the treatment of Parkinson's disease.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
50 mg$35In StockIn Stock
100 mg$56In StockIn Stock
500 mg$156-In Stock
1 mL x 10 mM (in DMSO)$40In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.82%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Piribedil AI Summary
Piribedil demonstrates a diverse spectrum of bioactivities. It is potent in inhibiting the Menin-MLL interaction in MLL-related leukemias and affects several signaling pathways including NFkB, ERK, and mitochondrial processes. The compound modulates various enzymes and receptors, showing activity against acetylcholine muscarinic M1 receptor, USP2a, histone modifiers such as GCN5L2, G9a, Pin1, and binding affinity to receptors like DRD2, SLC6A2, ADRA2C, SLC6A4, DRD3, and HRH1. Additionally, it inhibits the transport activities of human BSEP, MRP2, MRP3, and MRP4. In relation to safety, Piribedil is primarily associated with moderate liver toxicity, indicated by elevated levels of serum ALT, AST, and alkaline phosphatase, although there is no evidence of severe liver conditions like cirrhosis or malignancies. The antiviral activities of Piribedil include inhibition of malarial parasites, Lassa and Ebola virus interactions, and SARS-CoV-2. Specifically, it shows some extent of inhibition on SARS-CoV-2 induced cytotoxicity in Vero E6 cells, although its effectiveness compared to the control arbidol is lower. The compound also shows a hit score indicative of low antiviral activity against SARS-CoV-2 in HRCE cells. Moreover, Piribedil inhibits human HDAC6 with stronger effectiveness on certain substrates and engages with various receptors with both agonistic and antagonistic activities. Despite its varied bioactivity, its notable involvement includes effects on mitochondrial division, enzyme modulation, and receptor binding..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Piribedil (Trivastan) is a dopamine D2 agonist, used in the treatment of Parkinson's disease.
Targets&IC50
D2 receptor:6.9(pKi), α2A-adrenoceptor:7.1(pKi), α2C-adrenoceptor:7.2(pKi)
SynonymsTrivastan, Trivastal, EU-4200, ET-495
Chemical Properties
Molecular Weight298.34
FormulaC16H18N4O2
Cas No.3605-01-4
SmilesC(N1CCN(CC1)C1=NC=CC=N1)C1=CC2=C(OCO2)C=C1
Relative Density.1.1183 g/cm3 (Estimated)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
Chloroform: Soluble
DMSO: 18.33 mg/mL (61.44 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (6.7 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.3519 mL16.7594 mL33.5188 mL167.5940 mL
5 mM0.6704 mL3.3519 mL6.7038 mL33.5188 mL
10 mM0.3352 mL1.6759 mL3.3519 mL16.7594 mL
20 mM0.1676 mL0.8380 mL1.6759 mL8.3797 mL
50 mM0.0670 mL0.3352 mL0.6704 mL3.3519 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Piribedil | purchase Piribedil | Piribedil cost | order Piribedil | Piribedil chemical structure | Piribedil formula | Piribedil molecular weight